Dr Antonina Kouli
I am a Research Associate interested in neuroinflammation and its role in neurodegenerative diseases. I recently completed my PhD in Clinical Neurosciences at the University of Cambridge, under the supervision of Prof. Roger Barker and Dr. Caroline Williams-Gray.
My current research focuses on characterizing the inflammatory changes in PD and evaluating their relationship with dementia and other symptoms. This work involves:
(i) a detailed neuropathological investigation in human postmortem PD and control brains,
(ii) analysis of peripheral immune markers such as proinflammatory cytokines and Toll-like receptors using flow cytometry and ELISA and
(iii) PET neuroimaging with the radioligands 11C-PK11195 (marker of activated microglia) and 18F-AV1451 (marker of tau accumulation) in newly-diagnosed Parkinson's patients.
Cross-sectional and cohort studies
Positron Emission Tomography (PET)
No collaborators listed
Associated News Items
Kouli A, Horne CB, Williams-Gray CH (2019), “Toll-like receptors and their therapeutic potential in Parkinson's disease and α-synucleinopathies.” Brain Behav Immun pii: S0889-1591(19)30082-0. doi: 10.1016/j.bbi.2019.06.042. [Epub ahead of print]
Kouli A, Torsney KM, Kuan WL (2018), “Parkinson’s Disease: Etiology, Neuropathology, and Pathogenesis.” Book Chapter In: Stoker TB, Greenland JC, editors. Parkinson’s Disease: Pathogenesis and Clinical Aspects [Internet]. Brisbane (AU): Codon Publications; 2018 Dec 21. Chapter 1.
Scott KM, Kouli A, Yeoh SL, Clatworthy MR and Williams-Gray CH (2018), “A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease ” Front Neurol 9:815.
Bhosale G, Sharpe JA, Koh A, Kouli A, Szabadkai G, Duchen MR. (2017), “Pathological consequences of MICU1 mutations on mitochondrial calcium signalling and bioenergetics.” Biochim Biophys Acta Mol Cell Res. Volume 1864, Issue 6